Published in Chem Biol Drug Des on March 30, 2010
Microfluidic system for facilitated quantification of nanoparticle accumulation to cells under laminar flow. Ann Biomed Eng (2012) 0.85
Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo. Bioconjug Chem (2011) 0.81
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR (1992) 17.71
The Xplor-NIH NMR molecular structure determination package. J Magn Reson (2003) 16.23
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (1998) 8.11
Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun (1983) 7.26
Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med (1999) 3.72
Topology of microvillar membrance hydrolases of kidney and intestine. Physiol Rev (1982) 3.52
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res (2000) 3.24
Internal coordinates for molecular dynamics and minimization in structure determination and refinement. J Magn Reson (2001) 2.75
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. Blood (2009) 2.54
Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli. Annu Rev Cell Biol (1986) 2.49
Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J Biol Chem (1993) 2.37
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol (2000) 2.18
Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J Cell Biol (1994) 1.80
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res (2002) 1.76
Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J Biol Chem (2006) 1.39
Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif. J Biol Chem (2002) 1.22
Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs. Ann N Y Acad Sci (2004) 1.14
Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res (2003) 1.11
A doxorubicin-CNGRC-peptide conjugate with prodrug properties. Biochem Pharmacol (2002) 1.10
The slow, tight binding of bestatin and amastatin to aminopeptidases. J Biol Chem (1985) 1.06
Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrin. J Biol Chem (2008) 1.03
Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13. Hum Gene Ther (2005) 0.98
cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo. Arterioscler Thromb Vasc Biol (2006) 0.96
Proteolysis in eucaryotic cells: aminopeptidases and dipeptidyl aminopeptidases of yeast revisited. Arch Biochem Biophys (1983) 0.93
Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif. Mol Immunol (2005) 0.90
[Leucine aminopeptidase (arylamidase) activity in the serum. Determination using leucine-p-nitroanilide as substrate]. Klin Wochenschr (1967) 0.89
Structure and function of aminopeptidase N. Adv Exp Med Biol (2000) 0.89
Conformational change of rabbit aminopeptidase N into enterocyte plasma membrane domains analyzed by flow cytometry fluorescence energy transfer. J Cell Biol (1989) 0.88
Aminopeptidase N in sera of healthy subjects is a different N-terminal processed derivative from the one obtained from maternal serum. Mol Genet Metab (1998) 0.81
Aminopeptidase N/CD13 targeting fluorescent probes: synthesis and application to tumor cell imaging. Peptides (2005) 0.81
Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides. Biochem Pharmacol (1985) 0.81
Novel, aberrantly truncated isoform of serum CD13 in a family with high serum aminopeptidase N (CD13) activity. Clin Chem (2001) 0.79
NGR and isoDGR are separate moieties binding to different receptors. Blood (2009) 0.79
[Aminopeptidases in ovarian carcinomas in relation to clinical and pathological findings. A biochemical and histochemical study]. Arch Gynakol (1970) 0.77
New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc (2002) 5.83
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS (2005) 3.71
Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med (2009) 3.46
Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci (2009) 2.60
A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1. Mol Cell (2008) 2.29
Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One (2010) 2.12
Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol Cell (2005) 2.11
The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol Cell (2012) 1.83
Processive phosphorylation of alternative splicing factor/splicing factor 2. Proc Natl Acad Sci U S A (2003) 1.75
Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev (2009) 1.65
Phosphorylation reaction in cAPK protein kinase-free energy quantum mechanical/molecular mechanics simulations. J Phys Chem B (2007) 1.55
Diagnosis and management of pituitary abscess: experiences from 33 cases. Clin Endocrinol (Oxf) (2011) 1.55
Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg (2011) 1.54
Phosphorylation driven motions in the COOH-terminal Src kinase, CSK, revealed through enhanced hydrogen-deuterium exchange and mass spectrometry (DXMS). J Mol Biol (2002) 1.53
Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. Proc Natl Acad Sci U S A (2006) 1.52
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Virol (2006) 1.47
Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. Diagn Microbiol Infect Dis (2008) 1.45
Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy. AIDS (2003) 1.44
Mass spectrometric and kinetic analysis of ASF/SF2 phosphorylation by SRPK1 and Clk/Sty. J Biol Chem (2005) 1.43
Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor α-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells. Endocrinology (2013) 1.43
Regulated cellular partitioning of SR protein-specific kinases in mammalian cells. Mol Biol Cell (2005) 1.42
Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis (2004) 1.41
Signposts along the NIH roadmap for reengineering clinical research: lessons from the Clinical Research Networks initiative. Arch Intern Med (2008) 1.33
Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS J (2011) 1.30
The structure of human CD23 and its interactions with IgE and CD21. J Exp Med (2005) 1.28
The role of the putative catalytic base in the phosphoryl transfer reaction in a protein kinase: first-principles calculations. J Am Chem Soc (2003) 1.26
Ligand-induced global transitions in the catalytic domain of protein kinase A. Proc Natl Acad Sci U S A (2009) 1.25
Ordered multi-site phosphorylation of the splicing factor ASF/SF2 by SRPK1. J Mol Biol (2007) 1.19
Catalytic mechanism of the topa quinone containing copper amine oxidases. Biochemistry (2002) 1.18
Coupled motions in the SH2 and kinase domains of Csk control Src phosphorylation. J Mol Biol (2005) 1.18
Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1. J Mol Biol (2008) 1.17
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15
Structural basis for the regulation of protein kinase A by activation loop phosphorylation. J Biol Chem (2012) 1.14
Structural similarity of a membrane protein in micelles and membranes. J Am Chem Soc (2007) 1.10
Contemplative/emotion training reduces negative emotional behavior and promotes prosocial responses. Emotion (2011) 1.10
Structural basis for peptide binding in protein kinase A. Role of glutamic acid 203 and tyrosine 204 in the peptide-positioning loop. J Biol Chem (2002) 1.08
Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases. J Mol Biol (2013) 1.08
Coupling phosphoryl transfer and substrate interactions in protein kinases. Biochim Biophys Acta (2005) 1.06
The link module from ovulation- and inflammation-associated protein TSG-6 changes conformation on hyaluronan binding. J Biol Chem (2003) 1.04
Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J Neurosurg (2010) 1.03
A novel disulfide bond in the SH2 Domain of the C-terminal Src kinase controls catalytic activity. J Mol Biol (2006) 1.03
Dynamic coupling between the SH2 domain and active site of the COOH terminal Src kinase, Csk. J Mol Biol (2004) 1.02
Proteins at work: a combined small angle X-RAY scattering and theoretical determination of the multiple structures involved on the protein kinase functional landscape. J Biol Chem (2010) 1.02
Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. J Biol Chem (2007) 0.99
Regiospecific phosphorylation control of the SR protein ASF/SF2 by SRPK1. J Mol Biol (2009) 0.99
Communication pathways between the nucleotide pocket and distal regulatory sites in protein kinases. Acc Chem Res (2004) 0.98
Wise use of wetlands: current state of protection and utilization of Chinese wetlands and recommendations for improvement. Environ Manage (2008) 0.97
Clinical value of preventative ileostomy following ultra-low anterior rectal resection. Cell Biochem Biophys (2013) 0.97
Phosphoryl transfer step in the C-terminal Src kinase controls Src recognition. J Biol Chem (2004) 0.96
Increased use of intramedullary nails for intertrochanteric proximal femoral fractures in veterans affairs hospitals: a comparative effectiveness study. J Bone Joint Surg Am (2012) 0.95
Nucleotide-induced conformational changes in the Saccharomyces cerevisiae SR protein kinase, Sky1p, revealed by X-ray crystallography. Biochemistry (2003) 0.95
A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. Otolaryngol Head Neck Surg (2006) 0.95
Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1. J Mol Biol (2010) 0.94
[Clinical and pathological features of anti-neutrophil cytoplasm antibody associated systemic vasculitis in children]. Zhonghua Er Ke Za Zhi (2003) 0.93
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? J Transl Med (2014) 0.92
Structures of the FXYD regulatory proteins in lipid micelles and membranes. J Bioenerg Biomembr (2007) 0.92
Exploring biomolecular machines: energy landscape control of biological reactions. Philos Trans R Soc Lond B Biol Sci (2006) 0.92
Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant (2005) 0.92
Mycobacterium tuberculosis Rv0899 adopts a mixed alpha/beta-structure and does not form a transmembrane beta-barrel. Biochemistry (2010) 0.91
Applying the brakes to multisite SR protein phosphorylation: substrate-induced effects on the splicing kinase SRPK1. Biochemistry (2011) 0.91
Comparison of urinary biomarkers for early detection of acute kidney injury after cardiopulmonary bypass surgery in infants and young children. Pediatr Cardiol (2012) 0.91
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP. Bioorg Med Chem Lett (2011) 0.91
SR protein kinase 1 is resilient to inactivation. Structure (2007) 0.90
Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care (2013) 0.89
Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice. Endocrinology (2013) 0.89
The RGG domain of Npl3p recruits Sky1p through docking interactions. J Mol Biol (2006) 0.89
Neuronal regeneration and protection by collagen-binding BDNF in the rat middle cerebral artery occlusion model. Biomaterials (2011) 0.89
A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC Cancer (2013) 0.88
C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1. Nucleic Acids Res (2011) 0.88
The associations between single nucleotide polymorphisms of DNA repair genes, DNA damage, and age-related cataract: Jiangsu Eye Study. Invest Ophthalmol Vis Sci (2013) 0.88
Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. Am J Med Genet A (2012) 0.87
Mechanistic insights into Sky1p, a yeast homologue of the mammalian SR protein kinases. Biochemistry (2002) 0.87
Nucleotide release sequences in the protein kinase SRPK1 accelerate substrate phosphorylation. Biochemistry (2012) 0.87
A supramolecular cross-linked conjugated polymer network for multiple fluorescent sensing. J Am Chem Soc (2012) 0.87
Structural evaluation of a novel pro-apoptotic peptide coupled to CNGRC tumor homing sequence by NMR. Chem Biol Drug Des (2006) 0.86
SRC tail phosphorylation is limited by structural changes in the regulatory tyrosine kinase Csk. J Biol Chem (2006) 0.86
Chemical clamping allows for efficient phosphorylation of the RNA carrier protein Npl3. J Biol Chem (2004) 0.85
Backbone and side chain 1H, 13C and 15N assignments for Escherichia coli SdiA1-171, the autoinducer-binding domain of a quorum sensing protein. J Biomol NMR (2005) 0.85
Regulating SR protein phosphorylation through regions outside the kinase domain of SRPK1. J Mol Biol (2011) 0.85
Selective decoration of metal nanoparticles inside or outside of organic microstructures via self-assembly of resorcinarene. ACS Nano (2010) 0.85
Broad disorder and the allosteric mechanism of myosin II regulation by phosphorylation. Proc Natl Acad Sci U S A (2011) 0.85
Molecular mechanisms of diabetic coronary dysfunction due to large conductance Ca2⁺-activated K⁺ channel impairment. Chin Med J (Engl) (2012) 0.85
Distal loop flexibility of a regulatory domain modulates dynamics and activity of C-terminal SRC kinase (csk). PLoS Comput Biol (2013) 0.84
Probing the nucleotide binding domain of the osmoregulator EnvZ using fluorescent nucleotide derivatives. Biochemistry (2002) 0.84
Copy number variations of DNA repair genes and the age-related cataract: Jiangsu Eye Study. Invest Ophthalmol Vis Sci (2013) 0.83
Pulse rate and behavioral state correlates after auditory, tactile, visual, and vestibular intervention in drug-exposed neonates. J Perinatol (2002) 0.83
Novel destabilization of nucleotide binding by the gamma phosphate of ATP in the yeast SR protein kinase Sky1p. Biochemistry (2003) 0.83
MiR-92a inhibits porcine ovarian granulosa cell apoptosis by targeting Smad7 gene. FEBS Lett (2014) 0.83
Role of the tail in the regulated state of myosin 2. J Mol Biol (2011) 0.82
MicroRNA involvement in a metastatic non-functioning pituitary carcinoma. Pituitary (2015) 0.81
A case of McCune-Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy. J Pediatr Endocrinol Metab (2011) 0.81
Substrate-specific reorganization of the conformational ensemble of CSK implicates novel modes of kinase function. PLoS Comput Biol (2012) 0.81
A detailed meta-analysis shows no association between TNF-α -308G/A polymorphism and different forms of glaucoma. Ophthalmic Res (2011) 0.81
The solution structure of rat Abeta-(1-28) and its interaction with zinc ion: insights into the scarcity of amyloid deposition in aged rat brain. J Biol Inorg Chem (2004) 0.81
Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport's syndrome. J Mol Diagn (2012) 0.81
Anti-obesity and anti-tumor pro-apoptotic peptides are sufficient to cause release of cytochrome c from vesicles. FEBS Lett (2007) 0.81
[Analysis of 1268 patients with chronic renal failure in childhood: a report from 91 hospitals in China from 1990 to 2002]. Zhonghua Er Ke Za Zhi (2004) 0.80
Regulatory and catalytic domain dynamics of smooth muscle myosin filaments. Biochemistry (2006) 0.80
Hierarchical self-assembly: well-defined supramolecular nanostructures and metallohydrogels via amphiphilic discrete organoplatinum(II) metallacycles. J Am Chem Soc (2013) 0.80